ASSERTIO THERAPEUTICS, INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
ASSERTIO THERAPEUTICS, INC. reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction of -$9.66 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-22.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesDeductions · last filed 2013-02-22
- ASSERTIO THERAPEUTICS, INC. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2012 was -$9.66M.
- ASSERTIO THERAPEUTICS, INC. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2011 was -$9.01M.
- ASSERTIO THERAPEUTICS, INC. sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2010 was -$13.78M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 12 month |
|---|---|
| 2012-12-31 | -$9.66M 10-K · filed 2013-02-22 |
| 2011-12-31 | -$9.01M 10-K · filed 2013-02-22 |
| 2010-12-31 | -$13.78M 10-K · filed 2013-02-22 |